Pharmalot
Pharmalot
Stop FollowingPharmalot
ABOUT
Ed Silverman is the founding editor of Pharmalot and a prize-winning journalist who has covered the pharmaceutical industry for the past 15 years for The Star-Ledger of New Jersey, The Pink Sheet and, currently, as an editor-at-large for Med Ad News and R&D Directions.
SNAPSHOT
- Description: Journalist. Trading frequency: Not Trading
- Interests: Retirement savings
COMPANY
Currently, there is no company profile for Pharmalot.
BLOG
Pharmalot
For the past four years, a go-to site for the latest news and discussion about the pharmaceutical industry and its many issues. Pharmalot offers a mix of news, commentary and insights about drug development; mergers and acquisitions; regulatory oversight; safety and pricing; legislation, litigation and ...More
marketing issues.
Book
Currently, there are no book details for Pharmalot.
Latest Comments
more »
- Hi Pnac,You raise a good po... on Vivus Omits FDA Rejection in Press Release Tout...
- Hello Folks,Thanks for all ... on MannKind's Afrezza Dealt Setback by FDA
- Dear Sune,What is it that y... on Patients Try Again to Break Genzyme Drug Patent
- Hi Folks,Thanks for your no... on Yet Another Johnson & Johnson Recall
- Hi Folks,Thanks for your th... on KV Pharmaceuticals Under Federal Scrutiny for P...
Latest comments on Pharmalot's Articles
- jameszicoma on Will Abbott's Meridia Withdrawal Help or Hurt D...
- jameszicoma on Will Abbott's Meridia Withdrawal Help or Hurt D...
- Mad Hedge Fund Trader on A 'Game Changing' Ruling for Pharma Whistleblowers
- einzling44 on Sanofi Ends Heart Med Trial Over Cardiovascular...
- MVSundance on For Pfizer, Is Taking Lipitor OTC a Good Idea?
LATEST ARTICLES & INSTAPOSTS
more »

